// App-Quantinova.ai

PO‐213 : The impact of persistence of cytogenetic abnormalities pre‐transplantation in AML and MDS – a single UK centre retrospective review

Researchers

Presenter

  • S Sivakumaran

Principal Investigators

  • A Bloor

  • J Murray

  • S Kulkarni

  • A-M Sjursen

  • M Dennis

Medical Centers

  • The Christie Hospital, Manchester, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • Tyrosine 3-Monooxygenase/Tryptophan 5-Monooxygenase Activation Protein Epsilon

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved